NIH-funded research R01 grant

How the body's early immune response affects sudden kidney injury

Official title: Role of the innate immune system in acute kidney injury

Funded at Vanderbilt University Medical Center · NIH-11353769 · Data updated 2026-11-12

This research looks at how early immune cells in the kidney affect sudden kidney damage and the healing that follows.

More Acute Kidney Injury research and trials

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionVanderbilt University Medical Center
NIH-funded
Lab location1 site (Nashville, United States)
Project startAugust 5, 2013
Project endMarch 31, 2027
Funding year2026
Award (this year)$686,704
NIH project number5R01DK095785-14
Project IDNIH-11353769 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates would be people who have recently experienced acute kidney injury due to low blood flow, surgery, sepsis, or similar events, or those able to donate blood or kidney tissue samples for research.

Less likely to help

People with stable chronic kidney disease unrelated to recent ischemic injury, or those who cannot provide samples or travel to the study site, are unlikely to benefit directly from this project.

What this research studies

Researchers are studying what immune cells like neutrophils and macrophages do after the kidney loses and then regains blood flow. They follow the timing and behavior of these cells, how they shift from promoting inflammation to supporting repair, and how neutrophils are cleared or leave the kidney. The team examines tissue, animal models, and human kidney samples to identify signals that control inflammation resolution. Their goal is to find biological steps that could be targeted to improve recovery after acute kidney injury.

Why it matters

Potential benefit: If successful, this work could point to new treatments that limit kidney damage and speed recovery after sudden injuries like ischemia.

How similar studies have gone: Prior animal and human-tissue studies indicate immune cells influence injury and repair in AKI, but the detailed mechanisms and effective treatments remain largely unproven.

Where this research is happening

  • Vanderbilt University Medical Center
    Nashville, United States
    Active

Researchers

  • Principal investigator: Harris, Raymond C. — Vanderbilt University Medical Center
  • Study coordinator: Harris, Raymond C.

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.